Suppr超能文献

相似文献

1
The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite control.
Purinergic Signal. 2017 Jun;13(2):143-152. doi: 10.1007/s11302-016-9544-1. Epub 2016 Nov 19.
3
Leukotriene B4 modulates P2X7 receptor-mediated Leishmania amazonensis elimination in murine macrophages.
J Immunol. 2014 May 15;192(10):4765-73. doi: 10.4049/jimmunol.1301058. Epub 2014 Apr 11.
5
Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection.
Int J Parasitol. 2008 Mar;38(3-4):417-29. doi: 10.1016/j.ijpara.2007.08.010. Epub 2007 Sep 20.
6
Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Immunol Lett. 2006 May 15;105(1):38-47. doi: 10.1016/j.imlet.2005.12.002. Epub 2006 Jan 13.
7
PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by (L.) .
Front Immunol. 2018 May 11;9:1021. doi: 10.3389/fimmu.2018.01021. eCollection 2018.
9
Periodate-oxidized ATP modulates macrophage functions during infection with Leishmania amazonensis.
Cytometry A. 2014 Jul;85(7):588-600. doi: 10.1002/cyto.a.22449. Epub 2014 May 7.
10
Distinct courses of infection with Leishmania (L.) amazonensis are observed in BALB/c, BALB/c nude and C57BL/6 mice.
Parasitology. 2016 May;143(6):692-703. doi: 10.1017/S003118201600024X. Epub 2016 Feb 19.

引用本文的文献

1
Altered purinergic P2X7 and A receptors signaling limits macrophage-mediated host defense in schistosomiasis.
Biomed J. 2024 Dec;47(6):100713. doi: 10.1016/j.bj.2024.100713. Epub 2024 Mar 3.
2
Purinergic signaling in the battlefield of viral infections.
Purinergic Signal. 2025 Feb;21(1):83-98. doi: 10.1007/s11302-023-09981-8. Epub 2023 Dec 1.
3
Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis.
Pharmaceutics. 2022 Nov 20;14(11):2528. doi: 10.3390/pharmaceutics14112528.
4
Purinergic modulation of the immune response to infections.
Purinergic Signal. 2022 Mar;18(1):93-113. doi: 10.1007/s11302-021-09838-y. Epub 2022 Jan 8.
5
Purinergic signaling: A new front-line determinant of resistance and susceptibility in leishmaniasis.
Biomed J. 2022 Feb;45(1):109-117. doi: 10.1016/j.bj.2021.06.003. Epub 2021 Jun 24.
6
P2RX7 at the Host-Pathogen Interface of Infectious Diseases.
Microbiol Mol Biol Rev. 2021 Jan 13;85(1). doi: 10.1128/MMBR.00055-20. Print 2021 Feb 17.
7
Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the Inositol Phosphorylceramide Synthase.
ACS Infect Dis. 2021 Jan 8;7(1):47-63. doi: 10.1021/acsinfecdis.0c00546. Epub 2020 Dec 8.
8
P2Y Receptor Induces Infection Control in a Mechanism Dependent on Caspase-1 Activation and IL-1 Secretion.
Mediators Inflamm. 2020 Oct 1;2020:2545682. doi: 10.1155/2020/2545682. eCollection 2020.
10
Inflammasomes and Leishmania: in good times or bad, in sickness or in health.
Curr Opin Microbiol. 2019 Dec;52:70-76. doi: 10.1016/j.mib.2019.05.005. Epub 2019 Jun 20.

本文引用的文献

1
Lack of a Functioning P2X7 Receptor Leads to Increased Susceptibility to Toxoplasmic Ileitis.
PLoS One. 2015 Jun 8;10(6):e0129048. doi: 10.1371/journal.pone.0129048. eCollection 2015.
2
P2X7 on Mouse T Cells: One Channel, Many Functions.
Front Immunol. 2015 May 19;6:204. doi: 10.3389/fimmu.2015.00204. eCollection 2015.
3
Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015.
Curr Infect Dis Rep. 2015 Jul;17(7):489. doi: 10.1007/s11908-015-0489-2.
6
Purinergic signalling and immune cells.
Purinergic Signal. 2014 Dec;10(4):529-64. doi: 10.1007/s11302-014-9427-2. Epub 2014 Oct 29.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验